Summary
Updated Aug 31, 2026
Jennifer Schneider is Director of VERTEX PHARMACEUTICALS INC / MA (VRTX). 1 SEC Form 4 filing on record, dated 5 May 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Jennifer Schneider has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Jennifer Schneider go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer Schneider files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Amit Sachdev - $28.38M of VRTX open-market activity in the last 12 months
- Reshma Kewalramani - $19.74M of VRTX open-market activity in the last 12 months
- Carmen Bozic - $11.31M of VRTX open-market activity in the last 12 months
- Charles F. Wagner Jr. - $6.38M of VRTX open-market activity in the last 12 months
- Duncan McKechnie - $5.66M of VRTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jennifer Schneider?
Jennifer Schneider is a corporate insider, tracked as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jennifer Schneider last file a Form 4?
The only primary Form 4 on record is dated 5 May 2026.
Where can I see all of Jennifer Schneider's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jennifer Schneider and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial